Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEIH.L Regulatory News (EIH)

  • There is currently no data for EIH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Net Asset Value(s)

18 Jun 2007 07:01

Evolvence India Holdings PLC18 June 2007 Evolvence India Holdings Announces its Net Asset Value* at 31 March 2007 •Company's net assets are US$ 67. 9 million and net asset value per share is US$ 1.044 New Delhi, India: 18 June 2007 - Evolvence India Holdings Plc ("EIH" or "theCompany"), an Isle of Man, private equity fund of funds holding company thatfocuses on India, today announced its unaudited net asset value as of March 31,2007, being its first update since admitting to AIM on 23 March 2007. The company's net assets, at that date, are valued at $ 67.9 million and netasset value per share is $ 1.044, based on 65 million ordinary shares issuedduring an initial public offering of common stock on AIM, a market of the LondonStock Exchange plc. EIH has committed $ 39.5 million of the net proceeds intoEvolvence India Fund ("EIF"), an established private equity fund of funds with aco-investment pool focusing on growth capital in India. The company has alsocommitted $ 6 million to the Evolvence India Life Sciences Fund, ("EILSF") aprivate equity fund for investments in life sciences businesses in India. EILSFhas completed its first investment of $ 5 million in an oncology centre based inBangalore, India. The company's investment objective is to give investors access to a diversifiedIndian private equity portfolio while mitigating issues usually associated withprivate equity investments, such as lack of liquidity and relatively largeminimum investment size. The company intends issuing regular NAV valuation updates at the end of eachquarter. Evolvence India Fund has reported an appreciation of 20% in its portfolio basedon its current size of $ 220 million. EIF's portfolio includes investments inseven private equity funds and five co-investments. The number of portfoliocompanies (direct and underlying fund investments) stands at 70 in welldiversified growth sectors of the Indian economy. The portfolio has had sixsuccessful full exits and three partial exits. The Fund expects a few moreliquidity events in the near term. Jay Jegannathan, CEO, Evolvence India Holdings, said: "Our significant on theground network in India, deep industry knowledge and global approach allows usto selectively capitalise on the range of opportunities available in the Indianprivate equity market. We are confident that all our investments through EIF andEILSF will result in sustainable value creation for our shareholders." India's economy grew 9.4 percent in the fiscal year that ended in March 31 2007,its fastest rate in 18 years and second only to China among major globaleconomies, according to Reuters report. Although inflation is now coming down,most economists say India's economy is continuing to grow well above itslong-term sustainable rate. In the past four years, gross domestic product hasgrown at an average annual rate of 8.6 per cent, triggering a reappraisal of thecountry's potential as a force in the world economy. India logged third-quarterGDP growth of 8.7 per cent and the Reserve Bank of India expects the economy togrow 8.5 per cent in 2007-08. *unaudited; adjusted for exchange rate "The growth rate is clearly impressive and we are confident of the long termgrowth prospects of the Indian economy. The Company is currently in advancedstages of finalising two investments which will be announced shortly," addedJegannathan. Results of EIH Operations: Amount raised in IPO: $ 65.0 million Net proceeds: $ 60.0 million Committed to Evolvence India Fund: $ 39.5 million Committed to Evolvence India Life Sciences Fund $ 6.0 million Uncommitted Capital $ 14.5 million Unaudited Valuation as of 31-3-2007* o Value of investments in EIF* $ 47.4 million o Value of investment in EILSF (at cost) $ 6.0 million o Uncommitted Capital $ 14.5 million o NAV $ 67.9 million o NAV per unit $ 1.044 * Adjusted for Exchange Rate - Ends- About Evolvence India Holding (EIH): EIH is an Isle of Man incorporated, private equity fund of funds holding companyfocused on India. EIH is promoted by Evolvence Capital Ltd, a Dubai basedalternative investment firm. EIH invests in India through Evolvence India Fundand Evolvence India Life Sciences Fund and the fund managers' network ofrelationships. The funds advisors are based in New Delhi and Hyderabad. Contacts: Evolvence India Holdings plcJay Jagennathan, Chief Executive Officer + (971) 4 3324033 Evolvence CapitalShilpa Mathai, Communications Manager + (971) 4 332 4033shilpa@evolvence.com Fairfax I.SJonathan Brown, Head of Smaller Companies + (44) 20 7460 4385 Seymour PierceJonathan Wright, Director, Corporate Finance + (44) 20 7107 8050 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
7th May 202011:49 amRNSResult of EGM and Notice of Cancellation
7th Apr 20207:00 amRNSProposed AIM Cancellation and Notice of EGM
2nd Apr 20205:38 pmRNSReturn of Capital and COVID-19 Update
6th Dec 20197:00 amRNSReturn of Capital
29th Nov 20197:00 amRNSDelisting Update
21st Nov 20197:00 amRNSMarket Update
30th Sep 20194:30 pmRNSInterim Results
30th Jul 201911:15 amRNSResult of AGM
28th Jun 20197:00 amRNSPosting of 2018 Annual Results and Notice of AGM
24th May 20195:53 pmRNSHolding(s) in Company
1st May 20197:00 amRNSReturn of Capital
4th Apr 20195:00 pmRNSSale of RSB and Return of Capital
25th Jan 20197:00 amRNSHolding(s) in Company
21st Jan 20196:13 pmRNSHolding(s) in Company
18th Jan 201911:37 amRNSHolding(s) in Company
28th Sep 20187:00 amRNSInterim Results
26th Jul 201811:05 amRNSResult of AGM
28th Jun 20187:00 amRNSPosting of 2017 Annual Report and Notice of AGM
28th Jun 20187:00 amRNSReturn of Capital
20th Mar 20181:00 pmRNSReplacement: Return of Capital
20th Mar 20187:00 amRNSReturn of Capital
29th Sep 20175:17 pmRNSHalf-year Report
29th Sep 20175:13 pmRNSReturn of capital
24th Jul 201710:54 amRNSResults of Annual General Meeting
26th Jun 20176:01 pmRNSDirectorate Change
26th Jun 20176:00 pmRNSPosting of 2016 Annual Report and Notice of AGM
9th Feb 20178:05 amRNSReturn of Capital
26th Jan 20175:08 pmRNSHolding(s) in Company
25th Jan 20179:30 amRNSHolding(s) in Company
5th Jan 20177:00 amRNSUpdate re EIF
30th Sep 20167:00 amRNSHalf-year Report
25th Jul 20161:24 pmRNSResult of AGM
27th Jun 20165:37 pmRNSPosting of Annual Report & Notice of AGM
27th Jun 20167:00 amRNSFinal Results
27th Jun 20167:00 amRNSReturn of Capital
30th Nov 20155:57 pmRNSHolding(s) in Company
30th Sep 20157:00 amRNSInterim Results
30th Jun 201511:53 amRNSResult of AGM
9th Jun 20154:00 pmRNSNotice of AGM
5th Jun 20154:35 pmRNSFinal Results
30th Sep 20147:00 amRNSHalf Yearly Report
14th Jul 20143:19 pmRNSReturn of Capital
30th Jun 201411:57 amRNSResult of AGM
4th Jun 20147:00 amRNSNotice of AGM
3rd Jun 20147:00 amRNSFinal Results
3rd Dec 201311:16 amRNSHolding(s) in Company
2nd Dec 20134:09 pmRNSHolding(s) in Company
28th Nov 20135:14 pmRNSHolding(s) in Company
27th Nov 20133:14 pmRNSSale of Interest in Gland Pharma Limited
22nd Nov 20139:15 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.